A detailed history of Gps Wealth Strategies Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 5,788 shares of AZN stock, worth $378,245. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,788
Previous 5,718 1.22%
Holding current value
$378,245
Previous $445,000 1.35%
% of portfolio
0.06%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$76.67 - $87.62 $5,366 - $6,133
70 Added 1.22%
5,788 $451,000
Q2 2024

Jul 16, 2024

BUY
$66.81 - $80.83 $12,359 - $14,953
185 Added 3.34%
5,718 $445,000
Q1 2024

Apr 30, 2024

SELL
$61.03 - $69.57 $20,017 - $22,818
-328 Reduced 5.6%
5,533 $374,000
Q4 2023

Jan 12, 2024

SELL
$61.89 - $69.28 $9,531 - $10,669
-154 Reduced 2.56%
5,861 $394,000
Q3 2023

Oct 25, 2023

SELL
$64.85 - $71.7 $1,945 - $2,151
-30 Reduced 0.5%
6,015 $407,000
Q1 2023

Apr 17, 2023

BUY
$63.15 - $71.6 $381,741 - $432,821
6,045 New
6,045 $419,000
Q2 2022

Jul 19, 2022

BUY
$59.26 - $71.14 $3,259 - $3,912
55 Added 0.96%
5,785 $382,000
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $1,080 - $1,276
20 Added 0.35%
5,730 $334,000
Q3 2021

Oct 20, 2021

BUY
$55.56 - $60.79 $50,615 - $55,379
911 Added 18.98%
5,710 $343,000
Q2 2021

Jul 19, 2021

SELL
$48.42 - $60.18 $7,263 - $9,027
-150 Reduced 3.03%
4,799 $287,000
Q1 2021

Apr 15, 2021

BUY
$47.16 - $54.44 $26,032 - $30,050
552 Added 12.55%
4,949 $246,000
Q4 2020

Feb 05, 2021

BUY
$48.52 - $58.02 $32,411 - $38,757
668 Added 17.91%
4,397 $220,000
Q3 2020

Feb 05, 2021

BUY
$53.07 - $61.1 $197,898 - $227,841
3,729 New
3,729 $204,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.